These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8537722)

  • 21. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 22. The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients.
    Tentori F; Zepel L; Fuller DS; Wang M; Bieber BA; Robinson BM; Pisoni RL
    Am J Kidney Dis; 2015 Sep; 66(3):536-9. PubMed ID: 26300197
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metastatic calcinosis or calciphylaxis--a case with a severe vascular calcification during intermittent hemodialysis].
    Pogglitsch H; Feldner H; Stöckl G; Holzer H
    Wien Med Wochenschr; 1970 Jul; 120(30):532-4. PubMed ID: 5523384
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.
    Fukagawa M; Yokoyama K; Koiwa F; Taniguchi M; Shoji T; Kazama JJ; Komaba H; Ando R; Kakuta T; Fujii H; Nakayama M; Shibagaki Y; Fukumoto S; Fujii N; Hattori M; Ashida A; Iseki K; Shigematsu T; Tsukamoto Y; Tsubakihara Y; Tomo T; Hirakata H; Akizawa T; ;
    Ther Apher Dial; 2013 Jun; 17(3):247-88. PubMed ID: 23735142
    [No Abstract]   [Full Text] [Related]  

  • 26. [Total parathyroidectomy without autotransplantation in the management of "refractory" renal hyperparathyroidism].
    Diaconescu MR; Glod M; Costea I; Grigorovici M; Diaconescu S
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):105-10. PubMed ID: 21688566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone disease in uremia.
    Coburn JW
    Henry Ford Hosp Med J; 1983; 31(4):217-20. PubMed ID: 6674267
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of bone mineral content in patients with chronic renal failure.
    Gava A; Zorzetto M; Coghetto F; Teodori T; Marazzato G
    Rays; 1986; 11(3):67-70. PubMed ID: 3602467
    [No Abstract]   [Full Text] [Related]  

  • 30. Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design.
    Fukuhara S; Akizawa T; Fukagawa M; Onishi Y; Yamaguchi T; Hasegawa T; Kurokawa K
    Ther Apher Dial; 2011 Apr; 15(2):169-75. PubMed ID: 21426510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.
    Fukagawa M; Akizawa T
    Ther Apher Dial; 2005 Feb; 9(1):1-2. PubMed ID: 15828896
    [No Abstract]   [Full Text] [Related]  

  • 32. Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm?
    Weiner DE; Winkelmayer WC
    Am J Kidney Dis; 2014 May; 63(5):854-8. PubMed ID: 24725918
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biochemical markers of bone formation in hemodialysis and after allotransplantation of cadaveric kidney].
    Ermakova IP; Pronchenko IA; Buzulina VP; Nikonova TIu; Borisova AV
    Ter Arkh; 2006; 78(10):73-6. PubMed ID: 17180944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperparathyroidism in urology].
    Koide T
    Clin Calcium; 2005 Dec; 15(12):73-8. PubMed ID: 16322677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H; Akizawa T
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of metabolic bone disease in haemodialysis patients.
    Hussain R; Ahmed A; Soomro AS; Chishty SH; Naqvi SA
    J Pak Med Assoc; 1996 Apr; 46(4):83-6. PubMed ID: 8991360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic bone disease in patients on maintenance hemodialysis.
    Ritz E; Malluche H; Bommer J; Mehls O; Krempien B
    Nephron; 1974; 12(5):393-404. PubMed ID: 4824048
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous bilateral quadriceps tendon rupture in a patient on hemodialysis.
    Anderson WE; Habermann ET
    Orthop Rev; 1988 Apr; 17(4):411-4. PubMed ID: 3405626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.